Category: Press Release - Page 202 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

Post published:August 11, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Post published:August 11, 2020
Post category:Press Release

Read more about the article MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Post published:August 6, 2020
Post category:Press Release

Read more about the article NeonMind Submits Application for Psilocybin Research to Health Canada

NeonMind Submits Application for Psilocybin Research to Health Canada

Post published:August 6, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:August 5, 2020
Post category:Press Release

Read more about the article Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule

Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule

Post published:August 5, 2020
Post category:Press Release

Read more about the article 4 Palliative Canadians Approved for Psilocybin Therapy Via First Legal Medical Exemption for Psilocybin in Canada since the 1970s

4 Palliative Canadians Approved for Psilocybin Therapy Via First Legal Medical Exemption for Psilocybin in Canada since the 1970s

Post published:August 4, 2020
Post category:Press Release

Read more about the article Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

Post published:August 4, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:July 31, 2020
Post category:Press Release

Read more about the article Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Post published:July 31, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.